Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Enzymatic measures of cholestasis (eg, alkaline phosphatase, 5’-nucleotidase, gamma-glutamyl transpeptidase)

INTRODUCTION

A number of blood tests are available that reflect the condition of the liver. The most common tests used in clinical practice include the serum aminotransferases, bilirubin, alkaline phosphatase, albumin, and prothrombin time. These tests are often referred to as "liver function tests," although this term is somewhat misleading since most do not accurately reflect how well the liver is functioning, and abnormal values can be caused by diseases unrelated to the liver. In addition, these tests may be normal in patients who have advanced liver disease.

Several specialized tests have also been developed (such as indocyanine green clearance), which, although uncommonly used in clinical practice, can measure specific aspects of hepatic function.

Despite their limitations, liver biochemical and function tests have many applications in clinical medicine:

They provide a noninvasive method to screen for the presence of liver disease. The serum aminotransferases, for example, are part of a panel of tests used to screen all blood donors in the United States for the presence of transmissible viruses.

They can be used to measure the efficacy of treatments for liver disease (such as immunosuppressant agents for autoimmune hepatitis). (See "Autoimmune hepatitis: Treatment".)

                

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2014. | This topic last updated: Dec 14, 2012.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Kaplan MM. Alkaline phosphatase. Gastroenterology 1972; 62:452.
  2. Alvaro D, Benedetti A, Marucci L, et al. The function of alkaline phosphatase in the liver: regulation of intrahepatic biliary epithelium secretory activities in the rat. Hepatology 2000; 32:174.
  3. Bates JM, Akerlund J, Mittge E, Guillemin K. Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe 2007; 2:371.
  4. Sussman HH. Structural analysis of human alkaline phosphatase. In: Human alkaline phosphatase, Stigbrand T, Fisher WH (Eds), Alan R Liss, New York 1984. p.87.
  5. Kaplan MM. Alkaline phosphatase. N Engl J Med 1972; 286:200.
  6. Cho SR, Lim YA, Lee WG. Unusually high alkaline phosphatase due to intestinal isoenzyme in a healthy adult. Clin Chem Lab Med 2005; 43:1274.
  7. BAMFORD KF, HARRIS H, LUFFMAN JE, et al. SERUM-ALKALINE-PHOSPHATASE AND THE ABO BLOOD-GROUPS. Lancet 1965; 1:530.
  8. Posen S. Alkaline phosphatase. Ann Intern Med 1967; 67:183.
  9. Clubb JS, Neale FC, Posen S. The behavior of infused human placental alkaline phosphatase in human subjects. J Lab Clin Med 1965; 66:493.
  10. GUTMAN AB. Serum alkaline phosphatase activity in diseases of the skeletal and hepatobiliary systems. A consideration of the current status. Am J Med 1959; 27:875.
  11. Brensilver HL, Kaplan MM. Significance of elevated liver alkaline phosphatase in serum. Gastroenterology 1975; 68:1556.
  12. Kaplan MM, Righetti A. Induction of rat liver alkaline phosphatase: the mechanism of the serum elevation in bile duct obstruction. J Clin Invest 1970; 49:508.
  13. Kaplan MM. Serum alkaline phosphatase--another piece is added to the puzzle. Hepatology 1986; 6:526.
  14. Hatoff DE, Hardison WG. Induced synthesis of alkaline phosphatase by bile acids in rat liver cell culture. Gastroenterology 1979; 77:1062.
  15. De Broe ME, Borgers M, Wieme RJ. The separation and characterization of liver plasma membrane fragments circulating in the blood of patients with cholestasis. Clin Chim Acta 1975; 59:369.
  16. POSEN S, NEALE FC, CLUBB JS. HEAT INACTIVATION IN THE STUDY OF HUMAN ALKALINE PHOSPHATASES. Ann Intern Med 1965; 62:1234.
  17. Bahr M, Wilkinson JH. Urea as a selective inhibitor of human tissue alkaline phosphatases. Clin Chim Acta 1967; 17:367.
  18. ARIAS IM, WOLFSON S, LUCEY JF, MCKAY RJ Jr. TRANSIENT FAMILIAL NEONATAL HYPERBILIRUBINEMIA. J Clin Invest 1965; 44:1442.
  19. Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 2000; 342:1266.
  20. Clarke, LC, Beck, E. Plasma "alkaline" phosphatase activity. I. Normative data for growing children. J Pediatr 1960; 36:355.
  21. Kuwana T, Sugita O, Yakata M. Reference limits of bone and liver alkaline phosphatase isoenzymes in the serum of healthy subjects according to age and sex as determined by wheat germ lectin affinity electrophoresis. Clin Chim Acta 1988; 173:273.
  22. Kattwinkel J, Taussig LM, Statland BE, Verter JI. The effects of age on alkaline phosphatase and other serologic liver function tests in normal subjects and patients with cystic fibrosis. J Pediatr 1973; 82:234.
  23. Salz JL, Daum F, Cohen MI. Serum alkaline phosphatase activity during adolescence. J Pediatr 1973; 82:536.
  24. HEINO AE, JOKIPII SG. Serum alkaline phosphatase levels in the aged. Ann Med Intern Fenn 1962; 51:105.
  25. Birkett DJ, Done J, Neale FC, Posen S. Serum alkaline phosphatase in pregnancy; an immunological study. Br Med J 1966; 1:1210.
  26. Connell MD, Dinwoodie AJ. Diagnostic use of serum alkaline phosphatase isoenzymes and 5-nucleotidase. Clin Chim Acta 1970; 30:235.
  27. Perrillo RP, Griffin R, DeSchryver-Kecskemeti K, et al. Alcoholic liver disease presenting with marked elevation of serum alkaline phosphatase. A combined clinical and pathological study. Am J Dig Dis 1978; 23:1061.
  28. Boyde TRC, Latner AL. Starch gel electrophoresis of transaminase in human tissue extracts and serum. Biochem J 1961; 82:52.
  29. Wilson JW. Inherited elevation of alkaline phosphatase activity in the absence of disease. N Engl J Med 1979; 301:983.
  30. Dalovisio JR, Blonde L, Cortez LM, Pankey GA. Subacute thyroiditis with increased serum alkaline phosphatase. Ann Intern Med 1978; 88:505.
  31. Fishman WH. Immunologic and biochemical approaches to alkaline phosphatase isoenzyme analysis: the Regan isoenzyme. Ann N Y Acad Sci 1969; 166:745.
  32. Shaver WA, Bhatt H, Combes B. Low serum alkaline phosphatase activity in Wilson's disease. Hepatology 1986; 6:859.
  33. Berman DH, Leventhal RI, Gavaler JS, et al. Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. Gastroenterology 1991; 100:1129.
  34. Lallès JP. Intestinal alkaline phosphatase: multiple biological roles in maintenance of intestinal homeostasis and modulation by diet. Nutr Rev 2010; 68:323.
  35. Siraganian PA, Mulvihill JJ, Mulivor RA, Miller RW. Benign familial hyperphosphatasemia. JAMA 1989; 261:1310.
  36. Goldberg DM. 5'nucleotidase: recent advances in cell biology, methodology and clinical significance. Digestion 1973; 8:87.
  37. Righetti A, Kaplan MM. Disparate responses of serum and hepatic alkaline phosphatase and 5' nucleotidase to bile duct obstruction in the rat. Gastroenterology 1972; 62:1034.
  38. Song CS, Kappas A, Bodansky O. 5'-nucleotidase of plasma membranes of the rat liver: studies on subcellular distribution. Ann N Y Acad Sci 1969; 166:565.
  39. Schlaeger R, Haux P, Kattermann R. Studies on the mechanism of the increase in serum alkaline phosphatase activity in cholestasis: significance of the hepatic bile acid concentration for the leakage of alkaline phosphatase from rat liver. Enzyme 1982; 28:3.
  40. Campbell DM. Determination of 5'-nucleotidase in blood serum. Biochem J 1962; 82:348.
  41. YOUNG II. Serum 5-nucleotidase; characterization and evaluation in disease states. Ann N Y Acad Sci 1958; 75:357.
  42. BARDAWILL C, CHANG C. SERUM LACTIC DEHYDROGENASE, LEUCINE AMINOPEPTIDASE AND 5-NUCLEOTIDASE ACTIVITIES: OBSERVATION IN PATIENTS WITH CARCINOMA OF THE PANCREAS AND HEPATOBILIARY DISEASE. Can Med Assoc J 1963; 89:755.
  43. Hill PG, Sammons HG. An assessment of 5'-nucleotidase as a liver-function test. Q J Med 1967; 36:457.
  44. Belfield A, Goldberg DM. Normal ranges and diagnostic value of serum 5'nucleotidase and alkaline phosphatase activities in infancy. Arch Dis Child 1971; 46:842.
  45. KOWLESSAR OD, HAEFFNER LJ, RILEY EM, SLEISENGER MH. Comparative study of serum leucine aminopeptidase, 5-nucleotidase and non-specific alkaline phosphatase in diseases affecting the pancreas, hepatobiliary tree and bone. Am J Med 1961; 31:231.
  46. Eschar J, Rudzki C, Zimmerman HJ. Serum levels of 5'-nucleotidase in disease. Am J Clin Pathol 1967; 47:598.
  47. Kater RM, Mistilis SP. Obstetric cholestasis and pruritus of pregnancy. Med J Aust 1967; 1:638.
  48. Seitanidis B, Moss DW. Serum alkaline phosphatase and 5'-nucleotidase levels during normal pregnancy. Clin Chim Acta 1969; 25:183.
  49. HUNTON DB, BOLLMAN JL, HOFFMAN HN 2nd. The plasma removal on indocyanine green and sulfobromophthalein: effect of dosage and blocking agents. J Clin Invest 1961; 40:1648.
  50. Goldberg DM. Structural, functional, and clinical aspects of gamma-glutamyltransferase. CRC Crit Rev Clin Lab Sci 1980; 12:1.
  51. Meister A. The gamma-glutamyl cycle. Diseases associated with specific enzyme deficiencies. Ann Intern Med 1974; 81:247.
  52. Szasz G. A kinetic photometric method for serum gamma-glutamyl transpeptidase. Clin Chem 1969; 15:124.
  53. ARONSEN KF, HANSON A, NOSSLIN B. THE VALUE OF GAMMA-GLUTAMYL TRANSPEPTIDASE IN DIFFERENTIATING VIRAL HEPATITIS FROM OBSTRUCTIVE JAUNDICE. A STATISTICAL COMPARISON WITH ALKALINE PHOSPHATASE. Acta Chir Scand 1965; 130:92.
  54. Lum G, Gambino SR. Serum gamma-glutamyl transpeptidase activity as an indicator of disease of liver, pancreas, or bone. Clin Chem 1972; 18:358.
  55. RUTTENBURG AM, GOLDBARG JA, PINEDA EP. SERUM GAMMA-GLUTAMYL TRANSPEPTIDASE ACTIVITY IN HEPATOBILIARY PANCREATIC DISEASE. Gastroenterology 1963; 45:43.
  56. Cabrera-Abreu JC, Green A. Gamma-glutamyltransferase: value of its measurement in paediatrics. Ann Clin Biochem 2002; 39:22.
  57. Betro MG, Oon RC, Edwards JB. Gamma-glutamyl transpeptidase in diseases of the liver and bone. Am J Clin Pathol 1973; 60:672.
  58. Rosalki SB, Tarlow D, Rau D. Plasma gamma-glutamyl transpeptidase elevation in patients receiving enzyme-inducing drugs. Lancet 1971; 2:376.
  59. Lamy J, Baglin MC, Ferrant JP, Weill J. [Decrease in serum gamma-glutamyltranspeptidase following abstention from alcohol]. Clin Chim Acta 1974; 56:169.
  60. Kaplan MM, et al. Biochemical basis for serum enzyme abnormalities in alcoholic liver disease. In: Early identification of alcohol abuse, Research Monograph No. 17, Chang NC, Chan NM (Eds), NIAAA, 1985. p.186.
  61. Barouki R, Chobert MN, Finidori J, et al. Ethanol effects in a rat hepatoma cell line: induction of gamma-glutamyltransferase. Hepatology 1983; 3:323.
  62. Ivanov E, Adjarov D, Etarska M, et al. Elevated liver gamma-glutamyl transferase in chronic alcoholics. Enzyme 1980; 25:304.
  63. Selinger MJ, Matloff DS, Kaplan MM. gamma-Glutamyl transpeptidase activity in liver disease: serum elevation is independent of hepatic GGTP activity. Clin Chim Acta 1982; 125:283.
  64. Burrows S, Feldman W, McBride F. Serum gamma-glutamyl transpeptidase. Evaluation in screening of hospitalized patients. Am J Clin Pathol 1975; 64:311.